Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

EF Hutton Maintains Buy on Modiv, Lowers Price Target to $17

Author: Benzinga Newsdesk | November 15, 2022 05:05am
EF Hutton analyst Gaurav Mehta maintains Modiv (NYSE:MDV) with a Buy and lowers the price target from $21 to $17.

Posted In: MDV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist